Skip to main content

Table 1 Number of patients, age at inclusion, allele frequencies and genotypes in patients and controls

From: APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

 

Number (Females/Males)

Age at inclusion ± SD

Allele frequencies (%)

Genotypes

   

ε2

ε3

ε4

ε2/ε2

ε2/ε3

ε2/ε4

ε3/ε3

ε3/ε4

ε4/ε4

Alzheimer patients

All 376

79.5 ± 8.2

7.3

53.1

39.6

0.3

7.4

6.6

28.2

42.3

15.2

 

F 263

80.3 ± 8.3

7.6

52.9

39.5

0.4

6.8

7.6

28.5

41.8

14.8

 

M 113

77.5 ± 7.6

6.6

53.5

39.8

0.0

8.8

4.4

27.4

43.4

15.9

Control persons

All 561

75.1 ± 7.3

11.3

74.3

14.3

0.7

17.1

4.1

55.8

20.0

2.3

 

F 338

74.7 ± 7.1

10.9

74.4

14.3

0.6

16.6

4.1

55.9

21.0

1.8

 

M 223

75.7 ± 7.5

11.9

73.8

14.3

0.9

17.9

4.0

55.6

18.4

3.1

  1. F = females
  2. M = males
  3. SD = Standard Deviation